Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2011

01-04-2011 | Original Article

Riboflavin Depletion Impairs Cell Proliferation in Adult Human Duodenum: Identification of Potential Effectors

Authors: Emi Nakano, Sohail Mushtaq, Paul R. Heath, Eun-Sook Lee, Jonathan P. Bury, Stuart A. Riley, Hilary J. Powers, Bernard M. Corfe

Published in: Digestive Diseases and Sciences | Issue 4/2011

Login to get access

Abstract

Background and Aims

Riboflavin (vitamin B2) is an essential dietary component with a known function in oxidative metabolism. Our previous data using a rat model of riboflavin deficiency suggested that riboflavin also functions as a luminal signaling molecule regulating crypt development and cell turnover. Riboflavin deficiency is prevalent in both high- and low-income countries across the globe. This study aims to establish whether riboflavin deficiency has consequences for gastrointestinal (GI) morphology in adults and what the effects and effectors of any such alteration may be.

Methods

Duodenal biopsies and blood samples were collected from a cross-section of gastroscopy patients. Crypt morphology and cell division were studied by immunohistochemistry, and biochemical riboflavin status was determined. Additionally a cell culture model of riboflavin deficiency was developed and analyzed using a combination of flow cytometry, and microarray and clonogenic assays.

Result

Duodenal crypts from subjects in the lowest quartile of riboflavin status were significantly shorter (P = 0.023), less cellular (P = 0.007), and had fewer cell divisions (P = 0.034) than the crypts of subjects in the top quartile of riboflavin status. Following riboflavin depletion of colon cells in culture, cell cycle slowed. Microscopy revealed impaired mitosis and accumulation of aneuploid cells. Alterations in gene expression profiles reflected this alteration, with several mitosis-related genes altered, including AspM, cyclin B1, and Birc5 downregulated and Kif23 upregulated. Riboflavin depletion in vitro caused irreversible loss of proliferative potential of cells.

Conclusions

Riboflavin depletion in adult humans impairs proliferation and proliferative potential of intestinal cells, which may have implications for gastrointestinal function.
Literature
1.
go back to reference Gastaldi G, Ferrari G, Verri A, Casirola D, Orsenigo MN, Laforenza U. Riboflavin phosphorylation is the crucial event in riboflavin transport by isolated rat enterocytes. J Nutr. 2000;130:2556–2561.PubMed Gastaldi G, Ferrari G, Verri A, Casirola D, Orsenigo MN, Laforenza U. Riboflavin phosphorylation is the crucial event in riboflavin transport by isolated rat enterocytes. J Nutr. 2000;130:2556–2561.PubMed
2.
go back to reference Hoppel CL, Tandler B. Riboflavin and mouse hepatic cell structure and function. Mitochondrial oxidative metabolism in severe deficiency states. J Nutr. 1975;105:562–570.PubMed Hoppel CL, Tandler B. Riboflavin and mouse hepatic cell structure and function. Mitochondrial oxidative metabolism in severe deficiency states. J Nutr. 1975;105:562–570.PubMed
3.
go back to reference Tu BP, Ho-Schleyer SC, Travers KJ, Weissman JS. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science. 2000;290:1571–1754.PubMedCrossRef Tu BP, Ho-Schleyer SC, Travers KJ, Weissman JS. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science. 2000;290:1571–1754.PubMedCrossRef
4.
go back to reference Williams EA, Rumsey RD, Powers HJ. An investigation into the reversibility of the morphological and cytokinetic changes seen in the small intestine of riboflavin deficient rats. Gut. 1996;39:220–225.PubMedCrossRef Williams EA, Rumsey RD, Powers HJ. An investigation into the reversibility of the morphological and cytokinetic changes seen in the small intestine of riboflavin deficient rats. Gut. 1996;39:220–225.PubMedCrossRef
5.
go back to reference Williams EA, Rumsey RD, Powers HJ. Cytokinetic and structural responses of the rat small intestine to riboflavin depletion. Br J Nutr. 1996;75:315–324.PubMedCrossRef Williams EA, Rumsey RD, Powers HJ. Cytokinetic and structural responses of the rat small intestine to riboflavin depletion. Br J Nutr. 1996;75:315–324.PubMedCrossRef
6.
go back to reference Yates CA, Evans GS, Powers HJ. Riboflavin deficiency: early effects on post-weaning development of the duodenum in rats. Br J Nutr. 2001;86:593–599.PubMedCrossRef Yates CA, Evans GS, Powers HJ. Riboflavin deficiency: early effects on post-weaning development of the duodenum in rats. Br J Nutr. 2001;86:593–599.PubMedCrossRef
7.
go back to reference Powers HJ, Weaver LT, Austin S, Beresford JK. A proposed intestinal mechanism for the effect of riboflavin deficiency on iron loss in the rat. Br J Nutr. 1993;69:553–561.PubMedCrossRef Powers HJ, Weaver LT, Austin S, Beresford JK. A proposed intestinal mechanism for the effect of riboflavin deficiency on iron loss in the rat. Br J Nutr. 1993;69:553–561.PubMedCrossRef
8.
go back to reference Williams EA, Powers HJ, Rumsey RD. Morphological changes in the rat small intestine in response to riboflavin depletion. Br J Nutr. 1995;73:141–146.PubMedCrossRef Williams EA, Powers HJ, Rumsey RD. Morphological changes in the rat small intestine in response to riboflavin depletion. Br J Nutr. 1995;73:141–146.PubMedCrossRef
9.
go back to reference Yates CA, Evans GS, Pearson T, Powers HJ. Absence of luminal riboflavin disturbs early postnatal development of the gastrointestinal tract. Dig Dis Sci. 2003;48:1159–1164.PubMedCrossRef Yates CA, Evans GS, Pearson T, Powers HJ. Absence of luminal riboflavin disturbs early postnatal development of the gastrointestinal tract. Dig Dis Sci. 2003;48:1159–1164.PubMedCrossRef
10.
go back to reference Powers HJ, Corfe BM, Nakano E (2010) Riboflavin in development and cell fate. In: Stanger O Springer (ed) Water soluble vitamins (in press). Powers HJ, Corfe BM, Nakano E (2010) Riboflavin in development and cell fate. In: Stanger O Springer (ed) Water soluble vitamins (in press).
11.
go back to reference Camporeale G, Zempleni J. Oxidative folding of interleukin-2 is impaired in flavin-deficient jurkat cells, causing intracellular accumulation of interleukin-2 and increased expression of stress response genes. J Nutr. 2003;133:668–672.PubMed Camporeale G, Zempleni J. Oxidative folding of interleukin-2 is impaired in flavin-deficient jurkat cells, causing intracellular accumulation of interleukin-2 and increased expression of stress response genes. J Nutr. 2003;133:668–672.PubMed
12.
go back to reference Manthey KC, Chew YC, Zempleni J. Riboflavin deficiency impairs oxidative folding and secretion of apolipoprotein B-100 in HepG2 cells, triggering stress response systems. J Nutr. 2005;135:978–982.PubMed Manthey KC, Chew YC, Zempleni J. Riboflavin deficiency impairs oxidative folding and secretion of apolipoprotein B-100 in HepG2 cells, triggering stress response systems. J Nutr. 2005;135:978–982.PubMed
13.
go back to reference Manthey KC, Rodriguez-Melendez R, Hoi JT, Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J Nutr Biochem. 2006;17:250–256. Epub 2005 Jun 13.PubMedCrossRef Manthey KC, Rodriguez-Melendez R, Hoi JT, Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J Nutr Biochem. 2006;17:250–256. Epub 2005 Jun 13.PubMedCrossRef
14.
go back to reference Werner R, Manthey KC, Griffin JB, Zempleni J. HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium. J Nutr Biochem. 2005;16:617–624.PubMedCrossRef Werner R, Manthey KC, Griffin JB, Zempleni J. HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium. J Nutr Biochem. 2005;16:617–624.PubMedCrossRef
15.
go back to reference Scaife RM. G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium. Mol Cancer Ther. 2004;3:1229–1237.PubMed Scaife RM. G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium. Mol Cancer Ther. 2004;3:1229–1237.PubMed
16.
go back to reference Igase M, Okura T, Nakamura M, Takata Y, Kitami Y, Hiwada K. Role of GADD153 (growth arrest- and DNA damage-inducible gene 153) in vascular smooth muscle cell apoptosis. Clin Sci (Lond). 2001;100:275–281.CrossRef Igase M, Okura T, Nakamura M, Takata Y, Kitami Y, Hiwada K. Role of GADD153 (growth arrest- and DNA damage-inducible gene 153) in vascular smooth muscle cell apoptosis. Clin Sci (Lond). 2001;100:275–281.CrossRef
17.
go back to reference Siassi F, Ghadirian P. Riboflavin deficiency and esophageal cancer: a case control-household study in the Caspian Littoral of Iran. Cancer Detect Prev. 2005;29:464–469.PubMedCrossRef Siassi F, Ghadirian P. Riboflavin deficiency and esophageal cancer: a case control-household study in the Caspian Littoral of Iran. Cancer Detect Prev. 2005;29:464–469.PubMedCrossRef
18.
go back to reference Brun TA, Chen J, Campbell TC, et al. Urinary riboflavin excretion after a load test in rural China as a measure of possible riboflavin deficiency. Eur J Clin Nutr. 1990;44:195–206.PubMed Brun TA, Chen J, Campbell TC, et al. Urinary riboflavin excretion after a load test in rural China as a measure of possible riboflavin deficiency. Eur J Clin Nutr. 1990;44:195–206.PubMed
19.
go back to reference Lakshmi AV. Riboflavin metabolism-relevance to human nutrition. Indian J Med Res. 1998;108:182–190.PubMed Lakshmi AV. Riboflavin metabolism-relevance to human nutrition. Indian J Med Res. 1998;108:182–190.PubMed
20.
go back to reference Shaw NS. Riboflavin status in late pregnancy, postpartum and cord blood. Nutr Res. 1993;13:147–155.CrossRef Shaw NS. Riboflavin status in late pregnancy, postpartum and cord blood. Nutr Res. 1993;13:147–155.CrossRef
21.
go back to reference Bates CJ, Powers HJ, Downes R, Brubacher D, Sutcliffe V, Thurnhill A. Riboflavin status of adolescent vs. elderly Gambian subjects before and during supplementation. Am J Clin Nutr. 1989;50:825–829.PubMed Bates CJ, Powers HJ, Downes R, Brubacher D, Sutcliffe V, Thurnhill A. Riboflavin status of adolescent vs. elderly Gambian subjects before and during supplementation. Am J Clin Nutr. 1989;50:825–829.PubMed
22.
go back to reference Gregory J, Lowe S (2000) National Diet and Nutrition Survey. Young people aged 4–18 years: report of the diet and nutrition survey. The Stationery Office. Gregory J, Lowe S (2000) National Diet and Nutrition Survey. Young people aged 4–18 years: report of the diet and nutrition survey. The Stationery Office.
23.
go back to reference Lopez R, Schwartz JV, Cooperman JM. Riboflavin deficiency in an adolescent population in New York City. Am J Clin Nutr. 1980;33:1283–1286.PubMed Lopez R, Schwartz JV, Cooperman JM. Riboflavin deficiency in an adolescent population in New York City. Am J Clin Nutr. 1980;33:1283–1286.PubMed
24.
go back to reference Ten State Nutrition Survey, Education and Welfare Publication number (HSM) 72-8134. Dept of Health, 1971. Ten State Nutrition Survey, Education and Welfare Publication number (HSM) 72-8134. Dept of Health, 1971.
25.
go back to reference Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson CL (2002) Dietary intake of macronutrients, micronutrients, and other dietary constituents: United States, 1988–94. National Center for Health Statistics. Bialostosky K, Wright JD, Kennedy-Stephenson J, McDowell M, Johnson CL (2002) Dietary intake of macronutrients, micronutrients, and other dietary constituents: United States, 1988–94. National Center for Health Statistics.
26.
go back to reference Powers HJ, Weaver LT, Austin S, Wright AJ, Fairweather-Tait SJ. Riboflavin deficiency in the rat: effects on iron utilisation and loss. Brit J Nutr. 1991;65(Suppl 3):487–496.PubMedCrossRef Powers HJ, Weaver LT, Austin S, Wright AJ, Fairweather-Tait SJ. Riboflavin deficiency in the rat: effects on iron utilisation and loss. Brit J Nutr. 1991;65(Suppl 3):487–496.PubMedCrossRef
27.
go back to reference Fairweather-Tait SJ, Powers HJ, Minski MJ, Whitehead J, Downes R. Riboflavin deficiency and iron absorption in adult Gambian men. Ann Nutr Metab. 1992;36(Suppl 1):34–40.PubMedCrossRef Fairweather-Tait SJ, Powers HJ, Minski MJ, Whitehead J, Downes R. Riboflavin deficiency and iron absorption in adult Gambian men. Ann Nutr Metab. 1992;36(Suppl 1):34–40.PubMedCrossRef
28.
go back to reference Hill MHE, Bradley A, Mushtaq S, Williams EA, Powers HJ. Effects of methodological variation on assessment of riboflavin status using the erythrocyte glutathione reductase activation coefficient. Br J Nutr. 2009;102:273–278.PubMedCrossRef Hill MHE, Bradley A, Mushtaq S, Williams EA, Powers HJ. Effects of methodological variation on assessment of riboflavin status using the erythrocyte glutathione reductase activation coefficient. Br J Nutr. 2009;102:273–278.PubMedCrossRef
29.
go back to reference Capo-chichi CD, Gueant JL, Feillet F, Namour F, Vidailhet M. Analysis of riboflavin and riboflavin cofactor levels in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2000;739:219–224.PubMedCrossRef Capo-chichi CD, Gueant JL, Feillet F, Namour F, Vidailhet M. Analysis of riboflavin and riboflavin cofactor levels in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2000;739:219–224.PubMedCrossRef
30.
go back to reference Chirakkal H, Leech SH, Brookes KE, Prais AL, Waby JS, Corfe BM. Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene. 2006;25:7192–7200.PubMedCrossRef Chirakkal H, Leech SH, Brookes KE, Prais AL, Waby JS, Corfe BM. Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene. 2006;25:7192–7200.PubMedCrossRef
31.
go back to reference Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics. 2007;23:3251–3253.PubMedCrossRef Subramanian A, Kuehn H, Gould J, Tamayo P, Mesirov JP. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics. 2007;23:3251–3253.PubMedCrossRef
32.
go back to reference Livak KJ, Schmittgen TD. Analysis of gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(Suppl 4):402–408.PubMedCrossRef Livak KJ, Schmittgen TD. Analysis of gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(Suppl 4):402–408.PubMedCrossRef
33.
go back to reference Said HM, Ma TY, Ortiz A, Moyer MP, Yanagawa N. Mechanism of riboflavin uptake by Caco-2 human intestinal epithelial cells. Am J Physiol. 1994;266:G15–G21.PubMed Said HM, Ma TY, Ortiz A, Moyer MP, Yanagawa N. Mechanism of riboflavin uptake by Caco-2 human intestinal epithelial cells. Am J Physiol. 1994;266:G15–G21.PubMed
34.
go back to reference Ding QM, Ko TC, Evers BM. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Am J Physiol. 1998;275:C1193–C1200.PubMed Ding QM, Ko TC, Evers BM. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Am J Physiol. 1998;275:C1193–C1200.PubMed
35.
go back to reference Aliaga JC, Deschenes C, Beaulieu JF, Calvo EL, Rivard N. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am J Physiol. 1999;277:G631–G641.PubMed Aliaga JC, Deschenes C, Beaulieu JF, Calvo EL, Rivard N. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am J Physiol. 1999;277:G631–G641.PubMed
36.
go back to reference Manthey KC, Rodriguez-Melendez R, Hoi JT, Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J Nutr Biochem. 2006;17:250–256.PubMedCrossRef Manthey KC, Rodriguez-Melendez R, Hoi JT, Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J Nutr Biochem. 2006;17:250–256.PubMedCrossRef
37.
go back to reference Avides MD, Glover DM. Abnormal spindle protein, asp, and the integrity of mitotic centrosomal microtubule organizing centers. Science. 1999;283:1733–1735.CrossRef Avides MD, Glover DM. Abnormal spindle protein, asp, and the integrity of mitotic centrosomal microtubule organizing centers. Science. 1999;283:1733–1735.CrossRef
38.
go back to reference Kouprina N, Pavlicek A, Collins NK, et al. The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein. Hum Mol Genet. 2005;14:2155–2165.PubMedCrossRef Kouprina N, Pavlicek A, Collins NK, et al. The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein. Hum Mol Genet. 2005;14:2155–2165.PubMedCrossRef
39.
go back to reference Sullivan M, Morgan DO. Finishing mitosis, one step at a time. Nature Rev Mol Cell Biol. 2007;8:894–903.CrossRef Sullivan M, Morgan DO. Finishing mitosis, one step at a time. Nature Rev Mol Cell Biol. 2007;8:894–903.CrossRef
40.
go back to reference De Vega L, Perez Fernandez R, Martin Mateo MC, et al. Study of the activity of glutathione-peroxidase, glutathione-transferase and glutathione reductase in renal transplants. Transplant Proc. 2003;35(Suppl 4):1346–1350.PubMedCrossRef De Vega L, Perez Fernandez R, Martin Mateo MC, et al. Study of the activity of glutathione-peroxidase, glutathione-transferase and glutathione reductase in renal transplants. Transplant Proc. 2003;35(Suppl 4):1346–1350.PubMedCrossRef
Metadata
Title
Riboflavin Depletion Impairs Cell Proliferation in Adult Human Duodenum: Identification of Potential Effectors
Authors
Emi Nakano
Sohail Mushtaq
Paul R. Heath
Eun-Sook Lee
Jonathan P. Bury
Stuart A. Riley
Hilary J. Powers
Bernard M. Corfe
Publication date
01-04-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1374-3

Other articles of this Issue 4/2011

Digestive Diseases and Sciences 4/2011 Go to the issue

Stanford Multidisciplinary Seminars

“War and Peace” with Barrett’s Esophagus

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.